EAM
GERN icon

Exome Asset Management’s Geron GERN Stock Holding History

Exome Asset Management’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,858,354
Closed -$2.55M – 72
2025
Q3 		$2.55M Sell
1,858,354
-1,556,023
-46% -$2.07M 1.54% 28
2025
Q2 		$4.81M Buy
3,414,377
+198,920
+6% +$282K 3.58% 4
2025
Q1 		$5.11M Buy
3,215,457
+1,654,305
+106% +$4.03M 4.54% 3
2024
Q4 		$5.62M Buy
1,561,152
+656,026
+72% +$2.62M 4.22% 3
2024
Q3 		$4.11M Buy
+905,126
New +$4.12M 2.78% 9
2024
Q2 		– Sell
-886,800
Closed -$2.93M – 61
2024
Q1 		$2.93M Buy
886,800
+279,300
+46% +$626K 2.51% 12
2023
Q4 		$1.28M Buy
+607,500
New +$1.18M 1.27% 31

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Exome Asset Management's GERN Position: Q4 2025 in Review

Exome Asset Management sold out of Geron (GERN) in Q4 2025, closing a stake of 1,858,354 shares — an estimated $2.55M sold.

Exome Asset Management first reported a position in GERN in Q4 2023 and held it in 7 quarters. The position peaked at $5.62M in Q4 2024. 262 funds tracked by Wall St. Rank hold GERN as of Q4 2025.

  • Exome Asset Management reported no remaining Geron position as of Q4 2025 after selling out during the quarter.
  • Exome Asset Management sold 1,858,354 Geron shares in Q4 2025, an estimated $2.55M.
  • Exome Asset Management first reported a position in Geron in Q4 2023 and held it in 7 quarters.
  • Exome Asset Management's Geron position peaked at $5.62M in Q4 2024.
  • 262 funds tracked by Wall St. Rank held Geron as of Q4 2025.

Based on Exome Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.